earnings
confidence high
sentiment positive
materiality 0.85
West Pharma Q3 net sales $706.5M (+28.9%); adj. EPS $2.06 (+79%); raises FY guidance, dividend up 5.9%
WEST PHARMACEUTICAL SERVICES INC
2021-Q3 EPS reported
$6.78
revenue$2,100,800,000
- Net sales of $706.5M grew 28.9% (organic +27.9%); reported diluted EPS $2.31 (+112%).
- Adjusted diluted EPS of $2.06 increased 79% YoY.
- Proprietary Products segment sales grew 36.9% to $577M; HVP portfolio led growth.
- Full-year 2021 net sales guidance raised to $2.800-$2.810B; adj. EPS to $8.40-$8.50.
- Quarterly dividend increased 5.9% to $0.18/share, payable Nov 17, 2021.